# Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

> **NCT07229807** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 119 (estimated)

## Conditions studied

- Influenza a

## Interventions

- **DRUG:** ZSP1273
- **DRUG:** Oseltamivir

## Key facts

- **NCT ID:** NCT07229807
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-22
- **Primary completion:** 2025-12-17
- **Final completion:** 2025-12-31
- **Target enrollment:** 119 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07229807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07229807, "Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07229807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*